HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $63,000 | -99.8% | 11,060 | -99.6% | 0.01% | -99.7% |
| Q4 2021 | $26,781,000 | +8.9% | 2,933,351 | +27.5% | 1.56% | +7.3% |
| Q3 2021 | $24,600,000 | +8.0% | 2,301,179 | +56.8% | 1.46% | +11.0% |
| Q2 2021 | $22,778,000 | +302.9% | 1,467,675 | +204.7% | 1.31% | +151.1% |
| Q1 2020 | $5,654,000 | +376.3% | 481,608 | +853.7% | 0.52% | +508.1% |
| Q4 2019 | $1,187,000 | -71.7% | 50,500 | -77.8% | 0.09% | -77.3% |
| Q3 2019 | $4,200,000 | -63.4% | 227,002 | -63.2% | 0.38% | -64.0% |
| Q2 2019 | $11,474,000 | +100.9% | 617,185 | +164.1% | 1.05% | +91.6% |
| Q1 2019 | $5,710,000 | -38.8% | 233,651 | -35.0% | 0.55% | -52.7% |
| Q4 2018 | $9,331,000 | -0.3% | 359,713 | +21.7% | 1.16% | +39.3% |
| Q3 2018 | $9,356,000 | -15.6% | 295,589 | +3.6% | 0.83% | +18.0% |
| Q2 2018 | $11,081,000 | +1231.9% | 285,229 | +846.6% | 0.71% | +394.4% |
| Q1 2018 | $832,000 | – | 30,133 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 8,648,252 | $238,692,000 | 35.08% |
| Broadfin Capital, LLC | 1,581,416 | $43,647,000 | 6.80% |
| Tavio Capital LLC | 351,729 | $9,708,000 | 4.58% |
| Mesirow Financial Investment Management, Inc. | 33,389 | $922,000 | 3.88% |
| Rubric Capital Management LP | 1,510,008 | $41,676,000 | 3.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,666,229 | $45,988,000 | 3.63% |
| First Light Asset Management, LLC | 473,275 | $13,062,000 | 2.87% |
| Asymmetry Capital Management, L.P. | 77,346 | $2,135,000 | 2.67% |
| Copernicus Capital Management, LLC | 108,000 | $2,981,000 | 2.38% |
| BRIDGER MANAGEMENT, LLC | 1,277,560 | $35,261,000 | 2.14% |